Online Order Get In Touch

What are you looking for?

π-Icosa AAV Serotype Screening Platform

  • With its proprietary π-Icosa High-capacity and High-precision AAV serotype screening platform PackGene aims to identify tissue-specific and maximally infective AAV serotypes for clinical trial development. High infectivity and tissue specificity can ultimately reduce the dosage and production cost of AAV-based gene therapies while simultaneously increasing safety and efficacy

Pi Icosa
Contact Us

Key Advantages

  • Capacity

    Our platform design results in higher library capacity

  • Precision

    Higher precision AAV-serotype screening

  • Efficacy

    High infectivity and tissue specificity can result in reduced dosage requirements that increase both safety and efficacy.

Intellectual Property

  • PackGene has three patents pending.

    Technology Platforms

    Screen the tissue-targeting AAVs to improve the efficiency

     

    Library＞1 billion mutants
    Screens AAVs for tissue specificity.

Contact Us

Download

Login

Don't have an account? Please register
Account*
Password*
Code*
Refresh
Forgot password?
Logging in indicates that you have read and accepted the Registration Agreement and User Agreement
Log in with other accounts

New User Registration

Already have an account?
First Name*
Middle Name
Last Name*
Organization*
Organization Type*
Country/State*
Email Address*
Code*
Set Password*
Confirm password*
Refferal Code*

Reset Password

Return to
Email*
Code*
New password*
Confirm password*

Google Account Binding

Organization*
Organization Type*
Country/State*